TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones
TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones Paris, France and Munich, Germany, July 25, 2024…
Global Sleep Testing Services Market Size To Worth USD 8.7 Billion By 2033 | CAGR of 4.14%
The Global Sleep Testing Services Market Size was Valued at USD 5.8 Billion in 2023 and the Worldwide Sleep Testing…
AB Akola Group plans another investment in biomethane gas production
AB Kaišiadorių Paukštynas, an indirect subsidiary of AB Akola Group, plans to build a biomethane production plant for 19.4 million…
EMC Shielding and Test Equipment Market Projected to Hit USD 17.0 Billion by 2034 with CAGR of 5.3% – Report by Transparency Market Research, Inc.
Expansion in automotive, healthcare, and consumer electronics industries offers significant opportunities for market players by driving the need for advanced…
Communication about the availability of 2024 H1 financial report
PRESS RELEASE JULY 25, 2024 Communication about the availability of 2024 H1 financial report Boulogne-Billancourt, 7/25/2024 – Renault SA announces…
Financial report – 2024 H1
Financial report – 2024 H1 Attachment RG_2024_H1_Results_Financial Report_EN Disclaimer: The above press release comes to you under an arrangement with…
Nissan’s contribution to Renault Group’s second quarter 2024 earnings
Press Release July 25, 2024 Nissan’s contribution to Renault Group’s second quarter 2024 earnings Nissan released today its results for…
With Important Product-Led Transition Year Underway, Stellantis Delivers €5.6 Billion Net Profit, €8.5 Billion AOI and 10% AOI Margin in the First Half of 2024
With Important Product-Led Transition Year Underway, Stellantis Delivers €5.6 Billion Net Profit, €8.5 Billion AOI(1) and 10% AOI Margin(2)…
Vidac Pharma publishes results of next-generation drug candidate tests in human and murine tumor models
London (UK), July 25, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage…
Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470
Press Release Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470 Recruitment continues…
Global Sales of Chaga Mushrooms Have Been Forecasted to Reach US$ 2.1 Million by 2034 | Fact.MR Report
Chaga Mushrooms Extensively Use in Treatment of Diabetes and High Cholesterol Issues. Rockville, MD., July 25, 2024 (GLOBE NEWSWIRE) —…
Nestlé reports half-year results for 2024
[Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and Deutsch (pdf)…
Idorsia announces financial results for the first half 2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 25, 2024 Idorsia Ltd (SIX: IDIA) today announced…
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to…
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised
Group sales were up by 5%1 at constant exchange rates (CER) (stable in CHF) in the first half, driven by…
↑